Respiratory failure & ventilation

Ventilatory ratio, dead space, and venous admixture in patients with acute respiratory distress syndrome

Br J AnaesthPublished Retrospective observational study

Authors' conclusion

VR is a useful aggregate variable associated with outcome, but variables not associated with ventilation (VCO2 and venous admixture) strongly contribute to the high values of VR seen in patients with severe illness.

Study context

Population
Mechanically ventilated patients with acute respiratory distress syndrome (ARDS) in the UK and Italy
Participants
641 participants
Exposure
Mild ARDS vs Moderate ARDS vs Severe ARDS
  • Mild ARDSn = 65
  • Moderate ARDSn = 363
  • Severe ARDSn = 213
Outcome
Relationship of VR with physiological dead space and VCO2
Methodological detailsmultinational (UK and Italy), Venous admixture measured (n=153) or estimated by PaO2/FiO2 (n=448); VCO2 estimated from Harris-Benedict resting energy expenditure
  • Multinational (UK and Italy)
  • Venous admixture measured (n=153) or estimated by PaO2/FiO2 (n=448); VCO2 estimated from Harris-Benedict resting energy expenditure

Main finding

As reported in the abstract

Ventilatory ratio (VR) at physiological dead space 0.6, VCO2 200

1.1

VR at physiological dead space 0.6, VCO2 250

1.4

VR at physiological dead space 0.6, VCO2 300

1.7

Observational data: associations, not effects.

Further findings

Mortality associated with VR

Estimate
VROR 2.5 (95% CI 1.8–3.5)
VRAdjusted for VD/VTphys, VCO2, PaO2/FiO2ORadj 1.2 (95% CI 0.7–2.1)

Independent predictors of ICU mortality

ORadj (95% CI)P value
VD/VTphys17.9 (1.8–185)P < 0.05
VCO20.99 (0.99–1.00)P < 0.001
PaO2/FiO20.99 (0.99–1.00)P < 0.001

Original publication

Ventilatory ratio, dead space, and venous admixture in patients with acute respiratory distress syndrome. Br J Anaesth. Published 2 December 2022. doi:10.1016/j.bja.2022.10.035

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.